Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| CBL | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 6.35E4 | Evidence |
O
|
||||
| CBL | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 4.90E4 | Evidence | |||||
| CBL | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 3.15E4 | Evidence |
|
||||
| CBL | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 1.58E4 | Evidence |
|
||||
| CBL | NCK2 | NCK2: Cytoplasmic protein NCK2 | 7.06E3 | Evidence | |||||
| CBL | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 1.91E3 | Evidence |
|
||||
| CBL | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 824.0 | Evidence | |||||
| CBL | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 401.0 | Evidence |
|
||||
| CBL | GRAP | GRAP: GRB2-related adapter protein | 296.0 | Evidence | |||||
| CBL | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 200.0 | Evidence |
O
|
||||
| CBL | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 156.0 | Evidence |
|
||||
| CBL | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 149.0 | Evidence | |||||
| CBL | SHC4 | SHC-transforming protein 4 | 149.0 | Evidence | |||||
| CBL | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 132.0 | Evidence | |||||
| CBL | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 121.0 | Evidence |
|
||||
| CBL | TESK1 | TESK1: Dual specificity testis-specific protein kinase 1 | 109.0 | Evidence | |||||
| CBL | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 101.0 | Evidence |
O
|
||||
| CBL | SYK | SYK: Tyrosine-protein kinase SYK | 96.50 | Evidence |
|
||||
| CBL | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 90.80 | Evidence |
|
||||
| CBL | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 89.30 | Evidence |
|
||||
| CBL | BMX | N/A | 89.30 | Evidence | |||||
| CBL | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 82.10 | Evidence | |||||
| CBL | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 80.00 | Evidence | |||||
| CBL | JAK1 | 80.00 | Evidence | ||||||
| CBL | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 79.90 | Evidence |
O
|
||||
| CBL | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 78.20 | Evidence |
O
|
||||
| CBL | CSK | CSK: Tyrosine-protein kinase CSK | 78.20 | Evidence | O | ||||
| CBL | LYN | LYN: Tyrosine-protein kinase Lyn | 78.20 | Evidence |
|
||||
| CBL | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 72.70 | Evidence |
O
|
||||
| CBL | KIT | KIT: Mast/stem cell growth factor receptor precursor | 72.70 | Evidence |
|
||||
| CBL | INSR | INSR: Insulin receptor precursor | 72.70 | Evidence |
|
||||
| CBL | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 67.1 | Evidence |
|
||||
| CBL | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 65.6 | Evidence | |||||
| CBL | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 59.60 | Evidence |
O
|
||||
| CBL | HCK | N/A | 59.60 | Evidence |
O
|
||||
| CBL | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 57.70 | Evidence | |||||
| CBL | TXK | TXK, PTK4: Tyrosine-protein kinase TXK | 52.50 | Evidence | |||||
| CBL | FGFR1 | FGFR1, FGFBR, FLG, FLT2: Basic fibroblast growth factor receptor 1 precursor | 49.10 | Evidence | |||||
| CBL | FGFR3 | FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor | 49.10 | Evidence | |||||
| CBL | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 49.10 | Evidence |
|
||||
| CBL | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 44.00 | Evidence |
O
|
||||
| CBL | EPHB1 | EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor | 40.50 | Evidence | |||||
| CBL | EPHA2 | EPHA2, ECK: Ephrin type-A receptor 2 precursor | 40.50 | Evidence |
|
||||
| CBL | FLT3 | FLT3, STK1: FL cytokine receptor precursor | 40.50 | Evidence | |||||
| CBL | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 37.90 | Evidence | |||||
| CBL | SORBS3 | SORBS3, SCAM1: Vinexin | 37.40 | Evidence | |||||
| CBL | MERTK | MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor | 36.60 | Evidence | |||||
| CBL | MET | MET: Hepatocyte growth factor receptor precursor | 36.60 | Evidence |
|
||||
| CBL | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 33.90 | Evidence | |||||
| CBL | EPHB2 | EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor | 32.80 | Evidence | |||||
| CBL | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 32.80 | Evidence | |||||
| CBL | SOS1 | SOS1: Son of sevenless homolog 1 | 31.20 | Evidence | |||||
| CBL | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 29.10 | Evidence | |||||
| CBL | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 28.90 | Evidence | |||||
| CBL | DUSP3 | DUSP3, VHR: Dual specificity protein phosphatase 3 | 28.20 | Evidence | |||||
| CBL | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 24.90 | Evidence |
|
||||
| CBL | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 22.30 | Evidence | |||||
| CBL | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 22.20 | Evidence |
|
||||
| CBL | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 20.50 | Evidence |
O
|
||||
| CBL | WASPIP | N/A | 16.60 | Evidence | |||||
| CBL | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 16.60 | Evidence |
O
|
||||
| CBL | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 16.40 | Evidence | |||||
| CBL | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 15.30 | Evidence | |||||
| CBL | LNK | SH2B3, LNK: SH2B adapter protein 3 | 15.10 | Evidence | |||||
| CBL | SLA2 | SLA2, C20orf156, SLAP2: Src-like-adapter 2 | 15.10 | Evidence |
|
||||
| CBL | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 15.00 | Evidence |
O
|
||||
| CBL | GAB1 | GAB1: GRB2-associated-binding protein 1 | 15.00 | Evidence | |||||
| CBL | CRKL | CRKL: Crk-like protein | 14.60 | Evidence |
O
|
||||
| CBL | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 14.60 | Evidence |
|
||||
| CBL | IRS1 | IRS1: Insulin receptor substrate 1 | 13.80 | Evidence | |||||
| CBL | SCML2 | SCML2: Sex comb on midleg-like protein 2 | 13.80 | Evidence | |||||
| CBL | STAT3 | 13.50 | Evidence | ||||||
| CBL | TUBA1 | TUBA4A, TUBA1: Tubulin alpha-4A chain | 13.50 | Evidence | |||||
| CBL | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 13.50 | Evidence | |||||
| CBL | H2-ALPHA | TUBA3C, TUBA2, TUBA3D: Tubulin alpha-3C/D chain | 13.40 | Evidence | |||||
| CBL | GSK3A | GSK3A: Glycogen synthase kinase-3 alpha | 13.2 | Evidence | |||||
| CBL | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 13.2 | Evidence | |||||
| CBL | TYRO3 | TYRO3, BYK, DTK, RSE, SKY: Tyrosine-protein kinase receptor TYRO3 precursor | 12.80 | Evidence | |||||
| CBL | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 12.70 | Evidence |
|
||||